NeoMatrix Therapeutics (NMT) Welcomes Joachim Kohn, PhD, FBSE as Chief Scientific Advisor

Neomatrix Therapeutics, Inc. is pleased to announce that Joachim Kohn, PhD has joined the company as its Chief Scientific Advisor.

April 22, 2025 — Dr. Kohn is a Distinguished Professor Emeritus at Rutgers University. He is the President of the International Union of Societies for Biomaterials and Science and Engineering and a member of the National Academy of Inventors. He is a national leader in the field of biomaterials and has 84 issued US Patents on novel biomaterials and seven companies have licensed his technologies. He is the scientific founder of three spin-off companies.

Neomatrix Therapeutics, Inc. believes the addition of Dr. Kohn to its team will bolster its success now and in the future.

Contact:

Richard A. Clark, M.D., President & Chief Scientific Officer raclark@neomatrixtx.com.